A detailed history of Citigroup Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Citigroup Inc holds 42,803 shares of JAZZ stock, worth $5.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,803
Previous 22,036 94.24%
Holding current value
$5.26 Million
Previous $2.35 Million 102.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.57 - $116.37 $2.09 Million - $2.42 Million
20,767 Added 94.24%
42,803 $4.77 Million
Q2 2024

Aug 12, 2024

SELL
$103.94 - $118.98 $4.58 Million - $5.25 Million
-44,098 Reduced 66.68%
22,036 $2.35 Million
Q1 2024

May 10, 2024

SELL
$115.19 - $132.77 $336,930 - $388,352
-2,925 Reduced 4.24%
66,134 $7.96 Million
Q4 2023

Feb 09, 2024

BUY
$114.26 - $136.0 $1.4 Million - $1.66 Million
12,238 Added 21.54%
69,059 $8.49 Million
Q3 2023

Nov 09, 2023

SELL
$122.0 - $145.31 $710,772 - $846,576
-5,826 Reduced 9.3%
56,821 $7.35 Million
Q2 2023

Aug 10, 2023

SELL
$122.5 - $147.16 $3.71 Million - $4.46 Million
-30,301 Reduced 32.6%
62,647 $7.77 Million
Q1 2023

May 11, 2023

SELL
$133.98 - $160.47 $526,273 - $630,326
-3,928 Reduced 4.05%
92,948 $13.6 Million
Q4 2022

Feb 09, 2023

SELL
$129.72 - $159.85 $1.65 Million - $2.04 Million
-12,750 Reduced 11.63%
96,876 $15.4 Million
Q3 2022

Nov 10, 2022

BUY
$126.59 - $161.18 $8.39 Million - $10.7 Million
66,272 Added 152.86%
109,626 $14.6 Million
Q2 2022

Aug 10, 2022

SELL
$141.59 - $168.66 $355,815 - $423,842
-2,513 Reduced 5.48%
43,354 $6.76 Million
Q1 2022

May 12, 2022

BUY
$129.64 - $160.7 $152,975 - $189,626
1,180 Added 2.64%
45,867 $7.14 Million
Q4 2021

Feb 10, 2022

SELL
$119.87 - $145.67 $3.72 Million - $4.52 Million
-31,037 Reduced 40.99%
44,687 $5.69 Million
Q3 2021

Nov 10, 2021

BUY
$128.64 - $184.79 $9.74 Million - $14 Million
75,724 New
75,724 $9.86 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.